NO20055601D0 - Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients - Google Patents

Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients

Info

Publication number: NO20055601D0
Authority: NO; Norway
Prior art keywords: hydrogel; active ingredients; pharmaceutical preparation; transdermal administration; transdermal
Prior art date: 2003-04-28

Application number

NO20055601A

Other languages

Norwegian (no)

Other versions

NO20055601L (en

Inventor

Patrick Franke

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-28

Filing date

2005-11-25

Publication date

2005-11-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33395772&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20055601(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-11-25 Application filed by Schering Ag filed Critical Schering Ag

2005-11-25 Publication of NO20055601D0 publication Critical patent/NO20055601D0/en

2006-01-26 Publication of NO20055601L publication Critical patent/NO20055601L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Oil, Petroleum & Natural Gas (AREA)
Physical Education & Sports Medicine (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Neurology (AREA)
Inorganic Chemistry (AREA)
Rheumatology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Emergency Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

NO20055601A 2003-04-28 2005-11-25 Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients NO20055601L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP03008856		2003-04-28
PCT/EP2004/004224 WO2004096191A1 (en)	2003-04-28	2004-04-21	Pharmaceutical composition in the form of a hydrogel for transdermal administration of active substances

Publications (2)

Publication Number	Publication Date
NO20055601D0 true NO20055601D0 (en)	2005-11-25
NO20055601L NO20055601L (en)	2006-01-26

Family

ID=33395772

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055601A NO20055601L (en)	2003-04-28	2005-11-25	Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients

Country Status (32)

Country	Link
EP (2)	EP1617827B1 (en)
JP (2)	JP4829102B2 (en)
KR (1)	KR101093999B1 (en)
CN (1)	CN1780610B (en)
AR (1)	AR044113A1 (en)
AT (2)	ATE385786T1 (en)
AU (1)	AU2004233572B2 (en)
BR (1)	BRPI0409918A (en)
CA (1)	CA2523734C (en)
CL (1)	CL2004000884A1 (en)
CO (1)	CO5640075A2 (en)
CR (1)	CR8059A (en)
CY (1)	CY1108069T1 (en)
DE (2)	DE502004006196D1 (en)
DK (1)	DK1617827T3 (en)
EA (1)	EA008686B1 (en)
EC (1)	ECSP056186A (en)
ES (2)	ES2300763T3 (en)
HR (1)	HRP20080178T3 (en)
JO (1)	JO2492B1 (en)
MX (1)	MXPA05011541A (en)
NO (1)	NO20055601L (en)
NZ (2)	NZ583760A (en)
PE (1)	PE20050461A1 (en)
PL (1)	PL1617827T3 (en)
PT (1)	PT1617827E (en)
RS (1)	RS51307B (en)
SI (1)	SI1617827T1 (en)
TW (1)	TWI343259B (en)
UA (1)	UA83036C2 (en)
WO (1)	WO2004096191A1 (en)
ZA (1)	ZA200509549B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0506139D0 (en) *	2005-03-24	2005-05-04	Transphase Ltd	A transdermal topical composition and its uses
GB0506141D0 (en) *	2005-03-24	2005-05-04	Transphase Ltd	A topical compostion and its uses
DE102005015128B4 (en) *	2005-03-31	2008-12-11	Bayer Schering Pharma Aktiengesellschaft	Wafers containing steroid hormones
DE102005035879A1 (en) *	2005-07-30	2007-02-01	Paul Hartmann Ag	Hydrogel useful as a wound filler or dressing comprises a gel-forming polysaccharide, an acrylic acid derivative and an electrolyte mixture
SE536091C2 (en) *	2011-04-14	2013-04-30	Pep Tonic Medical Ab	Pharmaceutical composition containing oxytocin or fragments or variants thereof and at least one non-ionic cellulose ether
JP5934781B2 (en) *	2011-04-25	2016-06-15	パーク、ジュン−ヒョン	External preparation composition for preventing hair loss and promoting hair growth
FR2976808B1 (en) *	2011-06-22	2013-06-28	Urgo Lab	FILMOGENE COMPOSITION AND USE THEREOF FOR THE TREATMENT OF HERPES
US9855211B2 (en) *	2013-02-28	2018-01-02	Novan, Inc.	Topical compositions and methods of using the same
DE102018213754A1 (en) *	2018-08-15	2020-02-20	Henkel Ag & Co. Kgaa	"Tris (hydroxymethyl-) aminomethane or its salts as an active ingredient to reduce sweat secretion"

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3341557A (en)	1961-06-05	1967-09-12	Upjohn Co	7-methyltestosterones
DE1182229B (en)	1960-11-16	1964-11-26	Upjohn Co	Process for the preparation of 7-methyl steroids
US3924004A (en)	1971-11-24	1975-12-02	Syntex Corp	Fatty alcohol-propylene carbonate-glycol solvent cream vehicle
US4000273A (en)	1973-11-01	1976-12-28	Richardson-Merrell Inc.	Method for the control of fertility
JPS5540604A (en) *	1978-09-14	1980-03-22	Mitsui Toatsu Chem Inc	Improved local topicum
FR2518879A1 (en) *	1981-12-30	1983-07-01	Besins Jean	Topical oestradiol compsns. - for treatment of disorders associated with menopause
JPS5970612A (en) *	1982-10-13	1984-04-21	Nippon Redarii Kk	Gel ointment base
DE3868248D1 (en) *	1987-05-27	1992-03-12	Burghart Kurt	TRANSDERMAL THERAPEUTICALLY ACTIVE PHARMACEUTICAL PREPARATION AND DEVICE FOR APPLYING THE PREPARATION.
DE58909570D1 (en)	1988-10-27	1996-02-22	Schering Ag	DEPOSIT CONTAINING MEANS OF TRANSDERMAL APPLICATION
AU677206B2 (en) *	1992-06-11	1997-04-17	Theratech, Inc.	The use of glycerin in moderating transdermal drug delivery
US5460620A (en) *	1992-07-31	1995-10-24	Creative Products Resource, Inc.	Method of applying in-tandem applicator pads for transdermal delivery of a therapeutic agent
AU3723695A (en)	1994-09-14	1996-03-29	Minnesota Mining And Manufacturing Company	Transdermal device for delivery of levonorgestrel
FR2732223B1 (en)	1995-03-30	1997-06-13	Sanofi Sa	PHARMACEUTICAL COMPOSITION FOR TRANSDERMAL ADMINISTRATION
DE19526864A1 (en)	1995-07-22	1997-01-23	Labtec Gmbh	Hormone patches
JPH09194396A (en)	1996-01-17	1997-07-29	Pola Chem Ind Inc	Matrix for percutaneous patch material
US5733565A (en)	1996-02-23	1998-03-31	The Population Council, Center For Biomedical Research	Male contraceptive implant
KR970064620A (en) *	1996-03-05	1997-10-13	임성기	Cyclosporin-containing external-use pharmaceutical composition
US5736128A (en) *	1996-05-14	1998-04-07	Isp Investments Inc.	Cosmetic composition for rejuvenation of skin without skin irritation
IL127189A0 (en)	1996-05-22	1999-09-22	Diversified Pharmaceuticals In	Compositions methods and devices for the transdermal delivery of drugs
IT1283102B1 (en) *	1996-06-06	1998-04-07	Permatec Nv	THERAPEUTIC COMPOSITION FOR THE TRANSDERMAL ADMINISTRATION OF AN ESTROGENIC OR PROGESTINIC ACTIVE SUBSTANCE OR OF THEIR MIXTURES
US5993787A (en)	1996-09-13	1999-11-30	Johnson & Johnson Consumer Products, Inc.	Composition base for topical therapeutic and cosmetic preparations
US20020012694A1 (en)	1997-09-17	2002-01-31	Alfred J. Moo-Young	Transdermal administration of ment
US6767902B2 (en)	1997-09-17	2004-07-27	The Population Council, Inc.	Androgen as a male contraceptive and non-contraceptive androgen replacement
CA2333985C (en)	1998-06-19	2007-04-10	Dirk Leysen	Testosterone derivative
FR2781666B1 (en) *	1998-07-30	2000-09-08	Oreal	SOLID COSMETIC COMPOSITION AND USES THEREOF
JP2935113B1 (en) *	1998-09-24	1999-08-16	小林製薬株式会社	Indomethacin transdermal absorbent
WO2000041702A1 (en)	1999-01-13	2000-07-20	Taisho Pharmaceutical Co., Ltd.	External steroid preparation
JP2000264899A (en) *	1999-01-13	2000-09-26	Taisho Pharmaceut Co Ltd	Topical steroid
JP2001139451A (en) *	1999-11-17	2001-05-22	Lion Corp	Gelatinous cosmetic
BR0116127A (en)	2000-12-15	2003-11-04	Akzo Nobel Nv	Compound, pharmaceutical composition, use of a compound, and, male contraceptive kit
DE10104327A1 (en) *	2001-01-24	2002-07-25	Schering Ag	New 11beta-halo-testosterone derivatives useful in male hormone replacement therapy and in male fertility control
DE10107663B4 (en)	2001-02-19	2004-09-09	Lts Lohmann Therapie-Systeme Ag	Testosterone-containing transdermal therapeutic system, process for its preparation and its use

2004
- 2004-03-25 JO JO200439A patent/JO2492B1/en active
- 2004-04-19 TW TW093110876A patent/TWI343259B/en not_active IP Right Cessation
- 2004-04-21 EP EP04728563A patent/EP1617827B1/en not_active Expired - Lifetime
- 2004-04-21 NZ NZ583760A patent/NZ583760A/en unknown
- 2004-04-21 CN CN2004800114045A patent/CN1780610B/en not_active Expired - Fee Related
- 2004-04-21 RS YUP-2005/0809A patent/RS51307B/en unknown
- 2004-04-21 KR KR1020057020394A patent/KR101093999B1/en not_active Expired - Fee Related
- 2004-04-21 CA CA002523734A patent/CA2523734C/en not_active Expired - Fee Related
- 2004-04-21 AT AT04728563T patent/ATE385786T1/en active
- 2004-04-21 EA EA200501583A patent/EA008686B1/en not_active IP Right Cessation
- 2004-04-21 WO PCT/EP2004/004224 patent/WO2004096191A1/en not_active Ceased
- 2004-04-21 ES ES04728563T patent/ES2300763T3/en not_active Expired - Lifetime
- 2004-04-21 DK DK04728563T patent/DK1617827T3/en active
- 2004-04-21 ES ES07075742T patent/ES2345458T3/en not_active Expired - Lifetime
- 2004-04-21 BR BRPI0409918-4A patent/BRPI0409918A/en not_active IP Right Cessation
- 2004-04-21 HR HR20080178T patent/HRP20080178T3/en unknown
- 2004-04-21 AU AU2004233572A patent/AU2004233572B2/en not_active Ceased
- 2004-04-21 DE DE502004006196T patent/DE502004006196D1/en not_active Expired - Lifetime
- 2004-04-21 PL PL04728563T patent/PL1617827T3/en unknown
- 2004-04-21 UA UAA200511102A patent/UA83036C2/en unknown
- 2004-04-21 DE DE502004011164T patent/DE502004011164D1/en not_active Expired - Lifetime
- 2004-04-21 EP EP07075742A patent/EP1875905B1/en not_active Expired - Lifetime
- 2004-04-21 NZ NZ543264A patent/NZ543264A/en not_active IP Right Cessation
- 2004-04-21 PT PT04728563T patent/PT1617827E/en unknown
- 2004-04-21 AT AT07075742T patent/ATE467412T1/en active
- 2004-04-21 JP JP2006505217A patent/JP4829102B2/en not_active Expired - Fee Related
- 2004-04-21 SI SI200430685T patent/SI1617827T1/en unknown
- 2004-04-21 MX MXPA05011541A patent/MXPA05011541A/en active IP Right Grant
- 2004-04-26 PE PE2004000409A patent/PE20050461A1/en not_active Application Discontinuation
- 2004-04-27 CL CL200400884A patent/CL2004000884A1/en unknown
- 2004-04-28 AR ARP040101436A patent/AR044113A1/en unknown
2005
- 2005-10-24 CR CR8059A patent/CR8059A/en unknown
- 2005-11-24 ZA ZA200509549A patent/ZA200509549B/en unknown
- 2005-11-25 EC EC2005006186A patent/ECSP056186A/en unknown
- 2005-11-25 NO NO20055601A patent/NO20055601L/en not_active Application Discontinuation
- 2005-11-25 CO CO05119657A patent/CO5640075A2/en not_active Application Discontinuation
2008
- 2008-05-13 CY CY20081100503T patent/CY1108069T1/en unknown
2010
- 2010-07-02 JP JP2010152291A patent/JP2010241824A/en active Pending

Also Published As

Publication number	Publication date
AU2004233572A1 (en)	2004-11-11
ES2345458T3 (en)	2010-09-23
EP1875905A3 (en)	2008-06-25
ZA200509549B (en)	2007-02-28
RS20050809A (en)	2007-09-21
CA2523734C (en)	2009-12-22
KR101093999B1 (en)	2011-12-15
ECSP056186A (en)	2006-04-19
NZ543264A (en)	2010-03-26
WO2004096191A1 (en)	2004-11-11
BRPI0409918A (en)	2006-04-25
MXPA05011541A (en)	2006-05-31
EP1875905A2 (en)	2008-01-09
EP1875905B1 (en)	2010-05-12
SI1617827T1 (en)	2008-06-30
CN1780610A (en)	2006-05-31
JO2492B1 (en)	2009-10-05
UA83036C2 (en)	2008-06-10
PL1617827T3 (en)	2008-07-31
HK1087633A1 (en)	2006-10-20
CR8059A (en)	2006-05-29
DE502004006196D1 (en)	2008-03-27
PT1617827E (en)	2008-04-30
AU2004233572B2 (en)	2010-07-15
TW200524644A (en)	2005-08-01
CA2523734A1 (en)	2004-11-11
KR20060007403A (en)	2006-01-24
NO20055601L (en)	2006-01-26
CN1780610B (en)	2010-06-09
CY1108069T1 (en)	2014-02-12
EA008686B1 (en)	2007-06-29
JP2010241824A (en)	2010-10-28
RS51307B (en)	2010-12-31
NZ583760A (en)	2011-10-28
JP2006524653A (en)	2006-11-02
EP1617827A1 (en)	2006-01-25
EP1617827B1 (en)	2008-02-13
CO5640075A2 (en)	2006-05-31
ATE385786T1 (en)	2008-03-15
ES2300763T3 (en)	2008-06-16
AR044113A1 (en)	2005-08-24
HRP20080178T3 (en)	2008-05-31
ATE467412T1 (en)	2010-05-15
EA200501583A1 (en)	2006-06-30
DK1617827T3 (en)	2008-06-02
TWI343259B (en)	2011-06-11
PE20050461A1 (en)	2005-08-13
JP4829102B2 (en)	2011-12-07
CL2004000884A1 (en)	2005-03-11
DE502004011164D1 (en)	2010-06-24

Publication	Publication Date	Title
EP1909772A4 (en)	2011-07-13	FORMULATION FOR TRANSDERMAL DRUG DELIVERY
NO20043998L (en)	2004-10-05	Oral administration for heavily soluble basic active ingredients
EP1513825A4 (en)	2011-01-05	ANTI-TUBERCULOUS DRUG: COMPOSITIONS AND METHODS
NO2013004I1 (en)	2013-03-18	axitinib, optionally in the form of a pharmaceutical accentible salt
IL231576A (en)	2015-09-24	Adamantyl-acetamide derivatives, pharmaceutical compositions comprising same and use thereof in the manufacture of medicaments
ZA200705750B (en)	2008-11-26	Compositions and methods for stabilizing active pharmaceutical ingredients
EP1789075A4 (en)	2009-07-01	ABSORPTION ENHANCING SUBSTANCES FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
EP1807146A4 (en)	2013-07-03	COMPOSITION FOR IMPROVING THE EFFICACY OF DRUG DELIVERY
IL178822A (en)	2013-07-31	4-phenylamino-quinazolin-6-yl-amides, pharmaceutical compositions comprising the same and use thereof in the preparation of medicaments for the treatment of proliferative disorders
ATE410167T1 (en)	2008-10-15	LIQUID PHARMACEUTICAL PALONOSETRON FORMULATIONS
WO2005065317A3 (en)	2006-01-19	Effervescent oral fentanyl dosage form
IL229510A0 (en)	2013-12-31	Dosage form containing pantoprazole as active ingredient
WO2007009806A3 (en)	2007-04-05	Solid dosage formulations of narcotic drugs having improved buccal adsorption
NO20014738L (en)	2001-10-23	Tolperisone-containing pharmaceutical preparation for oral administration
ATE262893T1 (en)	2004-04-15	DOSAGE FORMS FOR THE TREATMENT OF ORAL MYCOSES
NO20055601D0 (en)	2005-11-25	Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients
IS8430A (en)	2006-04-26	Medicines containing (2R) -2-propyl octanoic acid as the active ingredient
DE602005021475D1 (en)	2010-07-08	MAGENTRESISTENT PHARMACEUTICAL DOSAGE FORM WITH N- (2- (2-PHTHALIMIDOETHOXY) -ACETYL) -L-ALANYL-D-GLUTAMINE ACID (LK-423)
NO323466B1 (en)	2007-05-21	New quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives, processes for their preparation, use thereof in medicaments for the treatment of pain, and pharmaceutical compositions comprising such derivatives
AU2003257982A1 (en)	2004-02-16	Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
IS7383A (en)	2004-08-05	Dosage form with controlled release drug for administration
ATE460934T1 (en)	2010-04-15	PHARMACEUTICAL PREPARATIONS OF CIPROFLOXACIN
IL163984A0 (en)	2005-12-18	Method for producing crystals from active ingredients in medicaments, crystals obtained by said method, and use thereof in pharmaceutical formulation
GB0201607D0 (en)	2002-03-13	Formulation for the administration of medicinal substances
NO20043749L (en)	2004-09-07	Stable pharmaceutical preparation comprising torsemide modification II

Legal Events

Date	Code	Title	Description
2012-11-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application